Tectonic Therapeutic (TECX): LifeSci Capital Reiterates Buy Rating
On November 18, LifeSci Capital reiterated a Buy rating on Tectonic Therapeutic, Inc. (NASDAQ:TECX) stock with a price target of $88. Tectonic Therapeutic, Inc.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Baker Bros. Advisors Julian Baker And Felix Baker | 607,788 | $20,892,713 | 0.1% | |
| 2. | Braidwell LP Alex Karnal | 596,900 | $20,518,438 | -30% | 0.76% |
| 3. | Vestal Point Capital Ryan Wilder | 425,000 | $14,609,375 | +30% | 0.34% |
| 4. | OrbiMed Advisors Samuel Isaly | 226,600 | $7,789,375 | 0.14% | |
| 5. | Ikarian Capital Neil Shahrestani | 205,837 | $7,075,647 | +31% | 0.76% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $21.10 | 2,500 | $52,750.00 | 127,030 | 2026-02-11 | Filing | |
| $21.10 | 2,500 | $52,750.00 | 237,547 | 2026-02-11 | Filing | |
| $21.61 | 6,000 | $129,660.00 | 32,044 | 2026-02-10 | Filing | |
| $16.31 | 53,706 | $875,944.86 | 1,503,358 | 2025-04-11 | Filing | |
| $16.73 | 45,858 | $767,204.34 | 1,449,652 | 2025-04-10 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $35.00 | 43 | $1,505.00 | 55,285 | 2026-08-12 | Filing | |
| $35.00 | 172 | $6,020.00 | 55,285 | 2026-06-30 | Filing | |
| $30.00 | 1,065 | $31,950.00 | 67,682 | 2026-05-04 | Filing | |
| $31.05 | 1,000 | $31,050.00 | 68,747 | 2026-04-01 | Filing | |
| $30.00 | 10,000 | $300,000.00 | 69,747 | 2026-03-06 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,830,378 | $97,294,233 | 0% | |
| 2. | 1,204,891 | $41,418,128 | 1% | |
| 3. | 1,141,824 | $39,250,200 | 0.06% | |
| 4. | 862,592 | $29,651,600 | 0% | |
| 5. | 800,726 | $27,524,958 | 1.67% |